Scientists comment on the FDA approving Cobenfy (KarXT) for schizophrenia. Dr Sameer Jauhar, Senior Clinical Lecturer in Affective Disorders and Psychosis, Consultant Psychiatrist, King’s College, ...

“Low vaccine uptake likely has a more significant role in increased measles cases, with uptake rates below 90% particularly in younger age groups (Ho et al. Lancet). However, to determine the true ...

The vast majority of cases of measles in England are in unvaccinated children and young people and outbreaks are always driven by low vaccine coverage, but the proportion of measles cases in adults ...

Data published by the World Health Organisation looks at adolescent social media use and gaming. Prof Ben Carter, Professor of Medical Statistics, Institute of Psychiatry, Psychology & Neuroscience at ...

Parkinson’s is the fastest growing neurological condition in the world, affecting around 153,000 people in the UK. It affects the dopamine-producing neurons in the brain and leads to many symptoms, ...

A follow up of a phase 2 trial published in eClinicalMedicine looks at the effect of psilocybin versus escitalopram for depression. Dr James Rucker, Consultant Psychiatrist & Senior Clinical Lecturer ...